Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 2 39-2, 1996, Pages

  Zukowska Grojec, Zofia ^a   Dayao, Emmanuel K ^a   Karwatowska Prokopczuk, Ewa ^a   Hauser, Gabriel J ^a   Doods, Henri N ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

cold stress; mesenteric blood flow; nonadrenergic; sympathetic nerve activity; vascular resistance

Indexed keywords

NEUROPEPTIDE Y1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RESPONSE; COLD STRESS; CONTROLLED STUDY; MESENTERIC ARTERY; MESENTERY BLOOD FLOW; NERVE CONDUCTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; SYMPATHETIC NERVE; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0030001649     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.2.h796     Document Type: Article

References (25)

1. Ahlborg, G., and J. M. Lundberg. Splanchnic release of neuropeptide Y during prolonged exercise with and without beta-adrenergic blockade in healthy man. Clin. Physiol. Oxf. 11: 343-351, 1991.
2. Clarke, J. G., R. Kerwin, S. Larkin, Y. Lee, M. Yacoub, G. J. Davies, D. Hackett, D. Dawbarn, S. R. Bloom, and A. Maseri. Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1. 1057-1059, 1987.
3. Daniels, A., D. Heyer, A. Landavazo, J. J. Leban, and A. Spaltenstein. Neuropeptide Y Antagonists. Cleveland, OH: International Publishing Group, WO 94/00486, 1994.
4. 1-receptor antagonist BIBP3226. J. Pharmacol. Exp. Ther. In press.
5. Franco-Cereceda, A., A. Owall, G. Settergen, A. Sollevi, and J. M. Lundberg. Release of neuropeptide Y and noradrenaline from the human heart after aortic occlusion during coronary artery surgery. Cardiovasc. Res. 24: 241-246, 1990.
6. Grundemar, L., and R. Hakanson. Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms. Gen. Pharmacol 24: 785-796, 1993.
7. LeBlank, J., J. Cote, and A. Labrie. Plasma catecholamines and cardiovascular responses to cold and mental activity. J. Appl. Physiol. Respir. Environ. Exercise Physiol. 47: 1207-1211, 1979.
8. Lewandowski, J., P. Pruszczyk, B. Wocial, H. Ignatowska-Switalska, E. Romejko-Wolniewicz, and A. Madej-Firek. Sex hormonal modulation of neuropeptide Y and cardiovascular responses to stress in humans. In: Stress: Molecular, Genetic, and Neurobiological Advances, edited by R. McCarty, G. Aguilera, E. Sabban, and R. Kvetnansky. New York: Gordon & Breach. In press.
9. Maisel, A. S., N. A. Scott, H. J. Motulsky, M. C. Michel, L. H. Boublik, J. E. Rivier, M. Ziegler, R, S. Allen, and M. R. Brown. Elevation of plasma neuropeptide Y levels in congestive heart failure. Am. J. Med. 86: 43-48, 1989
10. Myers, A. K., M. Y. Farhat, C. A. Vaz, H. R. Keiser, and Z. Zukowska-Grojec. Release of immunoreactive neuropeptide Y by rat platelets. Biochem. Biophys. Res. Commun. 155: 118-122, 1988.
11. Pernow, J., J. M. Lundberg, L. Kaijser, P. Hjemdahl, E. Theodorsson-Norheim, A. Martinsson, and B. Pernow. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin. Physiol. Oxf. 6: 561-578, 1986.
12. 1 receptor antagonist: BIBP3226. Eur. J. Pharmacol. 271: R11-R13, 1994.
13. 1 antagonist. FEBS Lett 362: 192-196, 1995.
14. Solt, V. B., M. R. Brown, B. Kennedy, O. G. Kolterman, and M. G. Ziegler. Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. Am. J. Hypertens. 3: 823-828, 1990
15. Todd, G. L., F. C. Clayton, E. McKinney, M. Ruddel, J. Buell, and R. S. Eliot. Plasma catecholamine variations in physiologically reactive and nonreactive individuals to cold pressor test. In: Pathogenesis of Stress-induced Heart Disease, edited by R. E. Beamish, V. Panagia, and N. S. Dhalla. Boston, MA: Martinuas Nijhoff, 1979, p. 185-198.
16. Wahlestedt, C., R. Hakanson, C. A. Vaz, and Z. Zukowska-Grojec. Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro. Am. J. Physiol. 258 (Regulatory Integrative Comp. Physiol. 27): R736-R742, 1990.
17. Wahlestedt, C., and D. J. Reis. Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic targets? Annu. Rev. Pharmacol. Toxicol. 32: 309-352, 1993.
18. Westfall, T. C., S. Carpentier, X. Chen, M. N. C. Beinfeld, L. Naes, and M. J. Meldrum. Prejunctional and postjunctional effects of neuropeptide Y at the noradrenergic neuroeffector junction of the perfused mesenteric arterial bed of the rat. J. Cardiovasc. Pharmacol. 10: 716-722, 1987.
19. Zukowska-Grojec, Z. Neuropeptide Y (NPY): a novel sympathetic stress hormone and more. Ann. NY Acad. Sci. In press.
20. Zukowska-Grojec, Z., and M. Haass. Stress-induced mesenterie vasoconstriction in rats is non-adrenergic. Federation Proc. 46: 1406, 1987.
21. Zukowska-Grojec, Z., M. Haass, and A. Bayorh. Neuropeptide Y and peptide YY mediate non-adrenergic vasoconstriction and modulate adrenergic responses in rats. Regul. Pept. 15: 99-110, 1986.
22. Zukowska-Grojec, Z., M. Konarska, and R. McCarty. Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. Life Sci. 42: 1615-1624, 1988.
23. Zukowska-Grojec, Z., G. H. Shen, P. A. Capraro, and C. A. Vaz. Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated. Physiol, Behav. 49: 771-777, 1991.
24. Zukowska-Grojec, Z., and C. A. Vaz. Role of neuropeptide Y (NPY) in the cardiovascular responses to stress. Synapse NY 2: 293-298, 1988.
25. Zukowska-Grojec, Z., and C. Wahlestedt. Sources and actions of neuropeptide Y in the cardiovascular system. In: Neuropeptide Y and Related Peptides, edited by W. Colmers and C. Wahlestedt. New York: Humana, 1993.